Concepedia

Effect of Anti‐CD 20 Antibody Rituximab in Patients with Post‐Transplant Lymphoproliferative Disorder (PTLD)

Stephan Oertel, Erik A.M. Verschuuren, Petra Reinke, Kristin Zeidler, Matthias Papp‐Váry, Nina Babel, Ralf Ulrich Trappe, Sven Jonas, Manfred Hummel, Ioannis Anagnostopoulos,

American Journal of Transplantation · 2005 · 259 citations · 20 references

DOI

Concepts

References

20

Reporting results of cancer treatment

A. B. Miller, Barth Hoogstraten, M. Staquet et al. · Cancer · 1981 · 7.9K citations

, , +16

REVERSIBILITY OF LYMPHOMAS AND LYMPHOPROLIFERATIVE LESIONS DEVELOPING UNDER CYCLOSPORIN-STEROID THERAPY

Thomas E. Starzl, K. A. Porter, Shunzaburo Iwatsuki et al. · The Lancet · 1984 · 1.3K citations · Full text

, , +6

Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study.

B. Coiffier, Corinne Haïoun, Nicolas Ketterer et al. · PubMed · 1998 · 898 citations

, , +15

Expression of Epstein–Barr Virus Transformation–Associated Genes in Tissues of Patients with EBV Lymphoproliferative Disease

Lawrence S. Young, Caroline Alfieri, Helen Evans et al. · New England Journal of Medicine · 1989 · 767 citations

, , +10

Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: A retrospective analysis on 32 patients

Nöel Milpied, B. Vasseur, Nathalie Parquet et al. · Annals of Oncology · 2000 · 376 citations · Full text

, , +16